XBIOTECH INC. Deferred Income Tax Liabilities, Net
XBIOTECH INC. (XBIT) had Deferred Income Tax Liabilities, Net of $5.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-13
- 2026-06-30: Deferred Income Tax Liabilities, Net $5.00K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $5.00K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $5.00K.
- 2024-12-31: Deferred Income Tax Liabilities, Net $0.00.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.00K 10-Q · filed 2026-08-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-13 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-15 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $59.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $872.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $873.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $873.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $873.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $108.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $108.00K 10-Q · filed 2021-08-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |